首页 | 本学科首页   官方微博 | 高级检索  
     


BRCA1 and BRCA2 germline mutations are frequently demonstrated in both high‐risk pancreatic cancer screening and pancreatic cancer cohorts
Authors:Aimee L. Lucas MD  MS  Laura E. Frado MD  Caroline Hwang MD  Sheila Kumar MD  Lauren G. Khanna MD  Elana J. Levinson MS  MPH  John A. Chabot MD  Wendy K. Chung MD  PhD  Harold Frucht MD
Affiliation:1. Division of Gastroenterology, Icahn School of Medicine at Mount Sinai, New York, New York;2. Muzzi Mirza Pancreatic Cancer Prevention and Genetics Program, Columbia University Medical Center, New York, New York;3. Division of Digestive and Liver Diseases, Department of Medicine, Columbia University, New York, New York;4. Department of Medicine, University of Southern California, Los Angeles, California;5. Department of Medicine, Stanford University, Palo Alto, California;6. Department of Pediatrics, Columbia University, New York, New York;7. Department of Medicine, Columbia University, New York, New York;8. Department of Surgery, Columbia University, New York, New York
Abstract:
Keywords:pancreatic neoplasms  pancreatic cancer screening  pancreatic cancer  diagnosis  BRCA1 gene  BRCA2 gene  genetic testing
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号